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There has been increasing rate of resistance to qui-
nolones and beta-lactam group of agents in Enterobac-
teriaceae members recently. The most frequently seen 
resistance mechanism against beta-lactam antibiotics 
is the production of extended spectrum beta-lactamase 
(ESBL) and the most common ESBLs are the plasmid-
borne CTX-M, SHV, and TEM types of enzymes 
(Pfeifer et al., 2010). Studies have reported that most 
of the ESBL-producing Enterobacteriaceae members are 
also resistant to fluoroquinolones (Nazik et al., 2011; 
Pasom et al., 2013; Kim et al., 2014). The role of muta-
tions occurring in the regions encoding DNA gyrase 
and topoisomerase IV enzymes and overexpression 
of efflux pumps in the resistance to fluoroquinolones 
have been known for a long time. The development of 
plasmid-borne resistance to quinolones in Enterobac- 
 ter ia ceae members was first reported in a  Klebsiella 
pneumoniae isolate. The Qnr protein, causes a low 
level quinolone resistance by binding to bacterial DNA 
gyrase and topoisomerase IV. The qnrA gene that had 
been seen in many Enterobacteriaceae members world-
wide was followed by qnrB, qnrC, qnrD, qnrS and qnrVC 
genes. The other more recent plasmid-borne resistance 
mechanisms include: qepA and oqxAB, which are efflux 
pump encoding genes, and aac(6’)-Ib-cr, which con-
tributes to the resistance by modifying ciprofloxacin 
(Pasom et al., 2013; Jacoby et al., 2014). The aim of this 
study was to explore various plasmid characteristics 
of ESBL-positive Escherichia coli and K. pneumoniae, 
which have been found to have plasmid-mediated qui-
nolone resistance.
The present study included four E. coli and four 
K. pneumoniae isolates, which were isolated from vari-
ous clinical specimens at the Medical Microbiology 
Department of Ege University Hospital. All the isolates 
were proved previously to be ESBL-positive by a double 
disk synergy test and to have at least one plasmid-
mediated quinolone resistance (PMQR) determinant 
(Hoşgör-Limoncu et al., 2012). Minimum inhibitory 
concentration (MIC) values of ciprofloxacin were deter-
mined using the microdilution method as suggested by 
the Clinical and Laboratory Standards Institute (CLSI). 
E. coli ATCC 25922 was used as the control strain.
Plasmids were isolated from the clinical bacte-
rial isolates and transconjugants by a commercial kit 
(QIAGEN plasmid maxi kit, Germany) according to the 
recommendations of the manufacturer. The qnrA, qnrB, 
qnrS, and qepA genes were explored in the isolated plas-
mids with the PCR method using original primers (Gay 
et al., 2006; Yamane et al., 2008; Minarini et al., 2008). 
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The aim of this study was to explore the plasmid characteristics of eight clinical Enterobacteriaceae strains containing extended broad spec-
trum beta-lactamases and plasmid-mediated quinolone resistance. Plasmids were transferred by conjugation or transformation and resist-
ance determinants were investigated by PCR. We showed that at least one plasmid harbouring qnrB or qnrS determinant was transferred by 
conjugation in five isolates. QepA determinant was confirmed to be on a non-conjugative plasmid. We found at least one beta-lactamase 
gene in seven of the eight clinical isolates having plasmid-mediated quinolone resistance, which indicated that these two resistance deter-
minants were mostly on the same conjugative plasmids.
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The positive control strains and plasmids used for qnrA, 
qnrB, qnrS, and qepA were E. coli j53 (pMG252), E. coli 
j53 (pMG298), E. coli J53 (pMG306) and pSTV28qepA, 
respectively (Hoşgör-Limoncu et al., 2012). 0.75% and 
1.5% agarose were prepared with 1 × TBE for plasmid 
DNA and PCR products, respectively.
The PMQR gene transfer was performed by the broth 
culture mating method using E. coli J53 AziR as a reci-
pient (Jacoby and Han, 1996). From the suspensions 
of 0.5 McFarland turbidity, first 0.1 ml of each donor 
strain and then 1 ml of recipient strain (E. coli J53 AziR) 
were inoculated into falcon tubes containing 4.5 ml 
of Luria-Bertani broth (LB-Becton, Dickinson). The 
tubes were incubated in a 35°C water bath for 18 hours. 
Transconjugants were selected on LB plates containing 
sodium azide (100 mg/l) (Sigma-Aldrich, Germany) and 
nalidixic acid (6 mg/l) (Sigma-Aldrich, Italy). The qnrA, 
qnrB, qnrS, and qepA genes were explored in the plas-
mids that were isolated from transconjugants with the 
PCR method using original primers (Gay et al., 2006; 
Yamane et al., 2008; Minarini et al., 2008).
The transformation of qnr plasmids to E. coli DH5α 
cells was performed by heat shock (Sambrook et al., 
1989). Competent E. coli DH5α suspension (200 µl) 
was transferred to sterile microcentrifuge tubes, and 
plasmid DNA (10 µl– 50 ng) was added to these tubes. 
The mixtures in the tubes were kept on ice for 30 min 
by stirring, and then they were kept 90 sec in a water 
bath adjusted to 42°C. At the end of the incubation they 
were quickly put on ice and kept there for 1–2 min. 
Finally, 800 µl of LB medium was added and they were 
kept for 45 min in a shaker incubator (250 rpm). The 
transformants were selected on LB agar plates contain-
ing ciprofloxacin (0.025–1 µg/ml), and their DNA was 
isolated to identify the relevant genes by PCR.
The presence of TEM, SHV and CTX-M beta- 
lactamase genes was explored by PCR in the clinical 
isolates with identified PMQR determinants and in 
their transconjugants-transformants (Taşlı and Bahar, 
2005, 2010).
Plasmids were isolated from the clinical strains 
harbouring PMQR determinants. These isolates were 
found to contain plasmids ranging from approximately 
1.5 kbp to 40 kbp. Conjugation experiments were car-
ried out to explore the transferability of plasmids hav-
ing PMQR determinants. It was observed that ~ 23 
and ~ 40 kbp plasmids of isolate 130 were transferred. 
From the three plasmids of isolate 151, only the one of 
~ 23 kbp was transferred; and from the two plasmids 
of isolate 160, only the one of ~ 23 kbp was transferred. 
From the two plasmids of isolates 134 and 146, only 
those plasmids of ~ 23 kbp were transferred. The plas-
mids of ~ 20 kbp of isolates 13 and 73 and the plasmid 
of ~ 23 kbp of isolate 140 could not be transferred to the 
recipient bacteria by conjugation.
The presence of PMQR determinants in the trans- 
conjugants was explored by PCR. It was verified that 
qnrB (in the ~ 23 kbp plasmid) in isolates 130 and 160, 
also qnrS (in the ~ 23 kbp plasmid) in isolate 151 were 
transferred. It was also verified with PCR that qnrB was 
transferred in isolates 134 and 146, but no qnrA deter-
minant could be detected in their conjugants (Fig. 1). 
Therefore, the ~ 23 kbp conjugative plasmids of iso-
lates 134 and 146 were revealed to carry qnrB determi-
nants but not qnrA. Transformation experiments were 
performed with the plasmids of these isolates, but no 
results could be obtained.
While the transformation trials failed for the plas-
mids of isolates 13 and 140, it was turned out success-
ful for the plasmid of isolate 73. The presence of qepA 
determinant was verified through the PCR made from 
the transformant of this strain (Fig. 1). The ciprofloxa-
cin MIC values of the transformant of isolate 73 and 
recipient strain were 0.2 µg/ml and 0.025 µg/ml, respec-
tively. The ciprofloxacin MIC value was increased 8-fold 
in the transconjugate.
The presence of TEM, SHV and CTX-M beta-lac-
tamase genes was explored by PCR in the eight clinical 
isolates harbouring PMQR determinants. TEM, SHV 
and CTX-M were seen together in three of the iso-
Fig. 1A. PCR results of qnrB and qnrS from transconjugants of the isolates and Fig. 1B. PCR result of qepA
from transformant of isolate 73.
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lates, TEM and CTX-M in two of them, and TEM and 
SHV in one. Only CTX-M was present in one isolate 
and none of these beta-lactamase determinants were 
encountered in another isolate (Table I). Transferabil-
ity of beta-lactamase genes by conjugation or transfor-
mation was explored by PCR in the isolates (73, 130, 
134 and 146). TEM and CTX-M beta-lactamase genes 
were found in the transformant of isolate 73 and in 
the transconjugants of isolates 130, 134 and 146. The 
SHV gene could not be detected in any of the examined 
transconjugants and transformants (Fig. 2).
Quinolones and beta-lactams are broad-spectrum 
antibiotics that are frequently used in both commu-
nity and hospital-acquired infections. Due to plasmids 
play an important role in the development of resist-
ance to these two antibiotic groups, it is important to 
investigate these plasmids in detail (Kanamori et al., 
2011, Jacoby et al., 2014; Zhao et al., 2015; Piekarska 
et al., 2015). In our study, we detected plasmids sized 
about 1.5–40 kbp in clinical isolates with established 
PMQR determinants. We found that at least one plas-
mid (~ 23 kbp) was transferred by conjugation in five 
of the eight clinical isolates included in our study. The 
presence of qnrB and qnrS in these conjugative plasmids 
was verified with PCR (Fig. 1), but no qnrA could be 
detected. Transformation was successful in one of the 
three isolates whose plasmids could not be transferred 
through conjugation. The presence of qepA in this iso-
late’s transformant was confirmed with PCR (Fig. 1). 
The ciprofloxacin MIC values of the transformant 
of isolate 73 and recipient strain were 0.2 µg/ml and 
0.025 µg/ml, respectively. The ciprofloxacin MIC value 
was increased 8-fold in the transconjugate.
In a study conducted in Turkey with ESBL-positive 
61 E. coli isolates, PMQR was found in only four iso-
lates, and from these only qnrA and qnrS could be trans-
ferred by conjugation but not qepA. The ciprofloxacin 
MIC values have been reported to increase 8 to 62-fold 
in transconjugates (Nazik et al., 2011). In a study made 
in Argentina, qnrB and aac(6’)-Ib-cr were transferred 
through conjugation but the qepA determinant could 
be transferred by electro-transformation (Rincón et al., 
2014). While they reported that qepA was on a plasmid 
of around 97 kbp, in our study we found a plasmid of 
around 20 kbp in the strain which qepA was detected. 
The increase they found in the ciprofloxacin MIC value 
of the transformant was also the same as found in our 
study. Very different conjugation rates of plasmids 
harbouring PMQR determinants may be encountered 
among studies, such as 17% and 40% (Cai et al., 2011; 
Pasom et al., 2013). The rate of success in the transfer 
of plasmids through conjugation is influenced by the 
 13 K. pneumoniae qnrS 1 – TEM SHV –
 73 E. coli qepA 1 1* TEM CTX-M TEM* CTX-M*
130 K. pneumoniae qnrB 2 2 TEM SHV CTX-M TEM CTX-M
134 K. pneumoniae qnrA qnrB 2 1 TEM SHV CTX-M TEM CTX-M
140 E. coli qnrB 1 – TEM CTX-M –
146 K. pneumoniae qnrA qnrB 2 1 TEM SHV CTX-M TEM CTX-M
151 E. coli qnrS 3 1 CTX-M –
160 E. coli qnrB 2 1 – –
Table I
Plasmids and beta-lactamase types of PMQR-positive clinical isolates and transconjugants (*Transformant)
Isolate Number/
Species
PMQR
determinant
Plasmid count Beta-lactamase type
Original strain Transconjugant Original strain Transconjugant
Fig. 2A. Presence of blaTEM, blaSHV (Fig. 2B) and blaCTX-M (Fig. 2C) genes in transconjugants and transformants.
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method used (e.g. “Filter mating”), recipient strains 
or antibiotics of varying effectiveness. Having carried 
out conjugation in five out of the eight clinical isolates 
in the present study, indicates a high rate of success. 
Similar to the results of some studies in the literature 
(Nazik et al., 2011; Rincón et al., 2014), we also found 
that the plasmid containing qepA is non-conjugative. 
However, Kim et al. (2014) stated that the qepA deter-
minant could be transferred through conjugation from 
all of the four isolates containing this determinant.
The presence of TEM, SHV and CTX-M beta-lac-
tamase genes was explored by PCR in the eight clinical 
isolates harbouring PMQR determinants. TEM, SHV 
and CTX-M were seen together in three of the isolates. 
Only CTX-M was present in one isolate and none of 
these beta-lactamase determinants were encountered 
in another isolate (Table I). Transferability of beta-
lactamase genes by conjugation or transformation was 
explored by PCR in the isolates (73, 130, 134 and 146). 
TEM and CTX-M beta-lactamase genes were found in 
the transformant of isolate 73 and in the transconju-
gants of isolates 130, 134 and 146. The SHV gene could 
not be detected in any of the examined transconjugants 
or transformants (Fig. 2).
As a result, we found at least one beta-lactamase 
gene in seven out of the eight clinical isolates containing 
PMQR determinants. We determined that the PMQR 
and beta-lactamase genes were on the same plasmid 
in three out of the four isolates harbouring beta-lacta-
mases and conjugative plasmids. The most frequently 
transferred beta-lactamase genes were blaTEM and 
blaCTX-M. We also found that the qepA determinant was 
transferred together with blaTEM and blaCTX-M. In our 
study, qnrB was found to be the most frequently trans-
ferred PMQR determinant.
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